Fennec Stock Based Compensation from 2010 to 2025

FRX Stock  CAD 10.63  0.00  0.00%   
Fennec Pharmaceuticals Stock Based Compensation yearly trend continues to be very stable with very little volatility. Stock Based Compensation is likely to grow to about 5.3 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2009-09-30
Previous Quarter
1.5 M
Current Value
2.2 M
Quarterly Volatility
653.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Fennec Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fennec Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 760 K, Interest Expense of 4.3 M or Selling General Administrative of 24.2 M, as well as many indicators such as Price To Sales Ratio of 3.45, Dividend Yield of 0.0 or Days Sales Outstanding of 93.98. Fennec financial statements analysis is a perfect complement when working with Fennec Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Fennec Pharmaceuticals Technical models . Check out the analysis of Fennec Pharmaceuticals Correlation against competitors.
To learn how to invest in Fennec Stock, please use our How to Invest in Fennec Pharmaceuticals guide.

Pair Trading with Fennec Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fennec Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Fennec Stock

  0.83IGM IGM FinancialPairCorr
  0.81GOOG Alphabet CDRPairCorr
  0.8GOOG Alphabet CDRPairCorr
  0.79POW PowerPairCorr
  0.77SAP Saputo IncPairCorr
The ability to find closely correlated positions to Fennec Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fennec Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fennec Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fennec Pharmaceuticals to buy it.
The correlation of Fennec Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fennec Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fennec Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fennec Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:
Check out the analysis of Fennec Pharmaceuticals Correlation against competitors.
To learn how to invest in Fennec Stock, please use our How to Invest in Fennec Pharmaceuticals guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.